Nordson completes acquisition of Atrion for $460 per share; borrows $825M

NORDSON CORP

Completed acquisition of Atrion Corp. on Aug 21, 2024; stockholders received $460.00 per share in cash.
Borrowed $500M under a 364-day term loan and $325M under revolving credit facility to fund the merger.
Atrion specializes in medical infusion fluid delivery and cardiovascular solutions, expanding Nordson's medical portfolio.
Atrion survives as a wholly owned subsidiary of Nordson after the merger.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.